Making Medicare Advantage profitable again
We're certainly not the first people to notice that, for health insurers, Medicare Advantage has lost a bit of its luster. During Q4 and Q1 earnings season, an unmistakable correlation was obvious: the greater an insurer's exposure to MA, the worse its performance on medical loss ratio—with knock-on effects on its stock price.

We’re certainly not the first people to notice that, for health insurers, Medicare Advantage has lost a bit of its luster. During Q4 and Q1 earnings season, an unmistakable correlation was obvious: the greater an insurer’s exposure to MA, the worse its performance on medical loss ratio—with knock-on effects on its stock price. The opposite was also true: the less the MA exposure, the better the overall MLR performance.
Union Healthcare Insight
Log in to continue reading
Not a member yet? Create a free account for limited access.
Related insights
This week in healthcare: What happened and what it means
What the 2026 midterm election results mean for healthcare policy
Healthcare policy and payment: What leaders need to know now